Arteriovenous fistulae (AVF) and grafts (AVG) for hemodialysis access generally provide good long-term solutions for the patient with endstage renal disease. However, complications of both AVGs and AVFs are common and require a multimodality approach to maintain their patency and continued use. Commonly encountered problems include stenosis, thrombosis, aneurysm or pseudoaneurysm formation, rupture, and infection. Each needs to be addressed on a case-by-case basis. Outflow stenosis, often occurring within the cephalic arch in patients with a brachiocephalic fistula, may occur alone or be discovered in conjunction with other access problems. Pseudoaneurysm of the venous end generally arises from traumatic weakening of the vessel wall, often from repetitive venipuncture. More rare is the fracture of a previously placed stent. We present a case of stent fracture complicated by pseudoaneurysm formation with concomitant stenosis of the cephalic arch treated successfully with single-procedure placement of endovascular stent grafts.
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CASE DESCRIPTION
A 49-year-old man with end-stage renal disease (ESRD) with a left upper extremity brachiocephalic fi stula presented with marked swelling of his left upper extremity. Ten months previously, he underwent placement of a stent graft (Fluency, Bard Peripheral, Tempe, AZ) for access site extravasation not amenable to conservative management. Th e left upper extremity was evaluated with sonography prior to the procedure and demonstrated a large pseudoaneurysm and associated hematoma (Figure 1) . Th e patient could not extend his elbow, and the decision was made to access the left cephalic vein via a right groin approach from the right common femoral vein.
After ultrasound-guided access using a standard Seldinger technique and placement of a vascular sheath, a 0.035-inch guidewire and 5F selective catheter were negotiated into the superior vena cava and into the left subclavian vein. Exchange was then made over an Amplatz guidewire (Boston Scientifi c, Natick, MA) for a 90 cm, 8F vascular sheath that was advanced into the left subclavian vein. Venography of the left cephalic vein was performed, confi rming extravasation into a pseudoaneurysm (Figure 2 ). An 8 mm × 15 cm Viabahn (WL Gore, Flagstaff , AZ) stent graft was advanced, and the pseudoaneurysm and fractured stent were covered. Repeat venogram under a digital subtraction technique demonstrated stagnant blood fl ow due to problems with the Fluency stent graft with a high rate of technical success and a low rate of complications (3). Cephalic arch stenosis is a commonly encountered problem with brachiocephalic fi stulae, reported to develop in up to 77% of cases. A retrospective study by Shawyer et al demonstrated the eff ective treatment of cephalic outfl ow stenoses with the Viabahn-covered stent graft, showing improved rates of access patency compared with the previously reported data for bare metal stents (4). Failure to address problems in the venous outfl ow as in our case can lead to early failure of corrective procedures performed for arteriovenous access problems elsewhere.
Rare but increasingly reported are stent fractures, a known complication of stent placement elsewhere in the body. Cases of fractured stents placed for the treatment of coronary artery disease (5), peripheral vascular diseases (6) , and chronic mesenteric ischemia (7) have been reported. Factors thought to contribute to stent fracture include placement in motionprone segments, compressive forces, stretching of the stent during placement, and the presence of overlapping stents (5-7). Stent fractures have been classifi ed in one system as type I to IV, with type I refl ecting a single strut fracture; type II, multiple strut fractures; type III, multiple strut fractures resulting in complete transverse fracture; and type IV, a complete transverse fracture with stent separation (7). In our reported case, a type IV fracture was clearly evident on fl uoroscopy, given the above parameters.
Pseudoaneurysms commonly arise at sites of cannulation through weakening of the vessel wall, although the development of pseudoaneurysms appears multifactorial, with high pressures from arterial fl ow and venous outfl ow stenosis being implicated. Th e presence of pseudoaneurysm is problematic and can lead to an increased risk of rupture with potential exsanguination, compromised viability of the overlying skin, limitations in the territory available for cannulation, infection, and cosmetic concerns. Indeed, the National Kidney Foundation guidelines recommend treatment when a pseudoaneurysm limits cannulation availability or when viability of the overlying skin becomes compromised (8) . Historically, surgical revision was required, although now there are numerous case reports of successful exclusion of the pseudoaneurysm via the placement of stent grafts (9) with or without thrombin injection (10) . Following placement of a stent graft, issues relative to cannulation territory may remain, and indeed it has been suggested that access through a stent graft should be avoided given potential complications and the lack of long-term safety data (11) . Th ese issues remain unresolved at present, and theoretical drawbacks of endovascular treatment must be carefully considered when either surgical revision or access abandonment appear to be the only options. Th e access in this case was salvaged by endovascular management and remained patent and usable at 10-month follow-up, despite necessary cannulation through the stent grafts. Baylor University Medical Center Proceedings Volume 26, Number 1
